About this trial
Objective: To determine the effect of Su Jok therapy on pain levels during the heel lance procedure in newborns. The study will be conducted as a randomized controlled experimental trial with a pretest-posttest control group design. The heel lance procedure will be video recorded, and pain assessment will be performed independently by an experienced neonatal intensive care nurse with 7 years of clinical expertise and a neonatologist, using validated pain assessment scales.
Eligibility criteria
Qualifiers
Term newborns (≥37 gestational weeks)
Without neurological disorders
Who have not undergone any painful procedure (e.g., injection, venipuncture) in the previous 24 hours
For whom heel lance for routine screening tests is planned
Disqualifiers
Clinically unstable infants before or during the procedure (e.g., respiratory distress, cardiac instability)
Infants whose position was changed, intervention was interrupted, or procedure repeated in a way that could affect pain perception
Parental withdrawal of consent during the procedure
Severe restlessness or sudden physiological changes preventing pain assessment
Trial design
Treatments tested in this trial
- Su Jok Application